3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Carcinoma, Ovarian Epithelial
9
Uterine Cervical Neoplasms
8
Breast Neoplasms
7
Testicular Neoplasms
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Ovarian Neoplasms
5
Neoplasms
5
Lymphoma, Non-Hodgkin
5
Lymphoma, Mantle-Cell
5
Lymphoma, Large-Cell, Immunoblastic
5
Lymphoma, Large B-Cell, Diffuse
5
Lymphoma, Follicular
5
Lymphoma, B-Cell, Marginal Zone
5
Leukemia, Myeloid, Chronic-Phase
5
Leukemia, Myeloid, Accelerated Phase
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Hodgkin Disease
5
Endometrial Neoplasms
5
Burkitt Lymphoma
5
Blast Crisis
5
Primary Myelofibrosis
4
Neuroblastoma
4
Multiple Myeloma
4
Leukemia, Myeloid, Acute
4
Leukemia, Hairy Cell
4
Recurrence
3
Pdgfra-Associated Chronic Eosinophilic Leukemia
3
Myeloproliferative Disorders
3
Lymphoma, T-Cell, Cutaneous
3
Leukemia, Neutrophilic, Chronic
3
Interventions
Hyperthermic Intraperitoneal Chemotherapy
28
Paclitaxel
24
Cisplatin
23
Oxaliplatin
18
Cytoreduction Surgical Procedures
17
Carboplatin
17
Fluorouracil
14
Bevacizumab
10
Mitomycin
9
Leucovorin
9
Doxorubicin
9
Docetaxel
6
Gemcitabine
5
130-nm albumin-bound paclitaxel
5
Surgical Procedures, Operative
4
Neoadjuvant Therapy
4
Laparoscopy
4
Blood Specimen Collection
4
Albumin-Bound Paclitaxel
4
sodium thiosulfate
3
liposomal doxorubicin
3
catumaxomab
3
Taxes
3
Drug Therapy
3
Chemotherapy, Adjuvant
3
tremelimumab
2
relacorilant
2
pembrolizumab
2
olaparib
2
nintedanib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Peritoneal Neoplasms
×
Therapeutics
×
Gynecologic
×
Clear all
NCT02840331
2017-10-27
Hypericin-PDT
University Hospital Tuebingen
Phase 3
Unknown
50 enrolled